Go Pro
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free STTK Stock Alerts

Shattuck Labs (STTK) Financials

Shattuck Labs logo
$6.57 -0.46 (-6.59%)
As of 02:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Shattuck Labs

Annual Income Statements for Shattuck Labs

This table shows Shattuck Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -24 -37 -45 -102 -87 -75 -49
Consolidated Net Income / (Loss)		 -24 -37 -45 -102 -87 -75 -49
Net Income / (Loss) Continuing Operations		 -24 -36 -45 -102 -87 -75 -49
Total Pre-Tax Income 		-24 -37 -45 -102 -87 -75 -49
Total Operating Income		 -25 -37 -45 -103 -92 -81 -52
Total Gross Profit		 9.89 9.93 30 0.65 1.66 5.72 1.00
Total Revenue		 9.89 9.93 30 0.65 1.66 5.72 1.00
Operating Revenue		 9.89 9.93 30 0.65 1.66 5.72 1.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 35 47 75 104 94 86 53
Selling, General & Admin Expense		 5.74 9.38 19 21 19 19 17
Research & Development Expense		 29 37 57 83 74 67 35
Total Other Income / (Expense), net		 1.09 0.33 0.30 1.38 4.66 5.16 2.70
Interest & Investment Income		 1.18 0.55 0.63 1.59 4.67 5.17 2.70
Other Income / (Expense), net		 -0.10 -0.22 -0.33 -0.21 -0.01 -0.02 -0.00
Basic Earnings per Share		 ($3.17) ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Weighted Average Basic Shares Outstanding		 7.56M 15.51M 42.03M 42.38M 42.60M 50.76M 69.58M
Diluted Earnings per Share		 ($3.17) ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Weighted Average Diluted Shares Outstanding		 7.56M 15.51M 42.03M 42.38M 42.60M 50.76M 69.58M
Weighted Average Basic & Diluted Shares Outstanding		 7.56M 15.51M 42.36M 42.45M 47.47M 47.90M 71.56M

Quarterly Income Statements for Shattuck Labs

This table shows Shattuck Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -27 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Consolidated Net Income / (Loss)		 -28 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Net Income / (Loss) Continuing Operations		 -28 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Total Pre-Tax Income 		-28 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Total Operating Income		 -29 -19 -20 -23 -18 -20 -14 -13 -11 -13 -16
Total Gross Profit		 0.69 0.71 1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00
Total Revenue		 0.69 0.71 1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00
Operating Revenue		 0.69 0.71 1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 29 20 21 25 21 20 14 13 12 13 16
Selling, General & Admin Expense		 5.07 4.44 4.90 5.33 4.60 4.25 4.47 4.35 4.10 4.32 4.60
Research & Development Expense		 24 15 16 19 16 15 9.92 8.68 7.62 9.06 11
Total Other Income / (Expense), net		 1.06 1.26 1.54 1.41 1.25 0.96 0.69 0.57 0.66 0.78 0.78
Interest & Investment Income		 - - - - - - 0.69 - - - 0.78
Other Income / (Expense), net		 1.06 -3.41 1.54 1.41 1.25 -4.21 -0.00 0.57 0.66 -1.93 -0.00
Basic Earnings per Share		 ($0.65) ($0.41) ($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13)
Weighted Average Basic Shares Outstanding		 42.48M 42.60M 50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M
Diluted Earnings per Share		 ($0.65) ($0.41) ($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13)
Weighted Average Diluted Shares Outstanding		 42.48M 42.60M 50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M
Weighted Average Basic & Diluted Shares Outstanding		 42.49M 47.47M 47.55M 47.73M 47.74M 47.90M 47.90M 47.90M 63.28M 71.56M 76.68M

Annual Cash Flow Statements for Shattuck Labs

This table details how cash moves in and out of Shattuck Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -25 151 -66 -45 78 -68 -3.20
Net Cash From Operating Activities		 -21 -34 -57 -94 -81 -61 -40
Net Cash From Continuing Operating Activities		 -21 -34 -57 -94 -81 -61 -40
Net Income / (Loss) Continuing Operations		 -24 -37 -45 -102 -87 -75 -49
Consolidated Net Income / (Loss)		 -24 -37 -45 -102 -87 -75 -49
Depreciation Expense		 0.54 0.62 1.38 3.07 4.04 3.83 3.69
Amortization Expense		 - 0.00 3.04 1.37 -1.48 -2.15 -0.45
Non-Cash Adjustments To Reconcile Net Income		 0.30 1.27 5.47 7.47 7.61 10 6.48
Changes in Operating Assets and Liabilities, net		 2.18 1.06 -22 -4.46 -4.10 3.02 -0.79
Net Cash From Investing Activities		 -3.59 -146 -10 49 111 -8.51 -7.89
Net Cash From Continuing Investing Activities		 -3.59 -146 -10 49 111 -8.51 -7.89
Purchase of Property, Plant & Equipment		 -0.47 -0.73 -7.93 -12 -0.41 -0.06 -0.07
Purchase of Investments		 -44 -183 -204 -132 -80 -94 -43
Sale and/or Maturity of Investments		 41 38 202 193 191 85 36
Net Cash From Financing Activities		 -0.06 331 1.93 0.17 49 0.79 45
Net Cash From Continuing Financing Activities		 -0.06 331 1.93 0.17 49 0.79 45
Repurchase of Common Equity		 -0.06 -19 - - - -0.02 0.00
Issuance of Common Equity		 0.00 233 1.93 0.17 49 1.26 45
Other Financing Activities, net		 0.00 - - 0.00 -0.05 -0.45 0.07

Quarterly Cash Flow Statements for Shattuck Labs

This table details how cash moves in and out of Shattuck Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -31 85 -44 -21 -17 14 3.51 -10 -7.92 12 36
Net Cash From Operating Activities		 -17 -19 -16 -11 -16 -17 -12 -10 -8.93 -8.49 -13
Net Cash From Continuing Operating Activities		 -16 -20 -11 -16 -16 -17 -12 -10 -8.93 -8.49 -13
Net Income / (Loss) Continuing Operations		 -28 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Consolidated Net Income / (Loss)		 -28 -18 -19 -22 -17 -19 -14 -12 -10 -13 -15
Depreciation Expense		 1.02 0.98 0.97 0.96 0.95 0.94 0.94 0.93 0.92 0.91 0.89
Amortization Expense		 -0.55 -0.43 -0.37 -0.62 -0.74 -0.42 -0.00 0.00 -0.17 -0.29 -0.05
Non-Cash Adjustments To Reconcile Net Income		 2.06 1.84 2.58 2.77 2.81 2.04 1.48 2.01 0.85 1.77 2.55
Changes in Operating Assets and Liabilities, net		 8.78 -4.62 4.54 2.14 -2.41 -1.25 -0.86 -0.92 -0.48 1.71 -2.05
Net Cash From Investing Activities		 -15 56 -33 -5.41 -0.82 31 16 - -43 20 24
Net Cash From Continuing Investing Activities		 -15 56 -33 -5.41 -0.82 31 16 - -43 20 24
Purchase of Investments		 -60 -4.93 -38 -25 -30 - 0.00 - -43 - -0.07
Sale and/or Maturity of Investments		 45 61 5.00 20 29 31 16 - - 20 24
Net Cash From Financing Activities		 0.02 49 -0.18 1.02 0.02 -0.07 -0.06 - 44 0.13 26
Net Cash From Continuing Financing Activities		 0.02 49 -0.18 1.02 0.02 -0.07 -0.06 - 44 0.13 26
Issuance of Common Equity		 0.02 49 0.61 0.67 0.04 -0.07 0.01 - 44 -0.01 21
Other Financing Activities, net		 - -0.01 -0.44 -0.01 -0.00 - -0.07 - - 0.14 5.18

Annual Balance Sheets for Shattuck Labs

This table presents Shattuck Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 45 349 299 205 160 91 91
Total Current Assets		 42 346 288 185 143 79 82
Cash & Equivalents		 7.01 158 92 47 126 57 54
Short-Term Investments		 32 178 177 114 5.00 16 24
Prepaid Expenses		 3.36 10 19 23 13 6.23 4.41
Plant, Property, & Equipment, net		 2.44 3.00 9.94 18 14 9.81 6.11
Total Noncurrent Assets		 0.09 0.35 0.38 3.07 2.54 2.02 2.44
Long-Term Investments		 - - - - - 0.00 1.00
Other Noncurrent Operating Assets		 0.09 0.35 0.38 3.07 2.54 2.02 1.44
Total Liabilities & Shareholders' Equity		 45 349 299 205 160 91 91
Total Liabilities		 30 39 27 29 15 11 8.64
Total Current Liabilities		 20 17 25 25 11 8.92 7.05
Accounts Payable		 3.05 1.75 10 7.17 1.59 2.42 2.10
Accrued Expenses		 4.04 7.35 15 18 9.87 6.50 4.95
Total Noncurrent Liabilities		 10 22 2.21 4.20 3.41 2.51 1.58
Other Noncurrent Operating Liabilities		 - - 0.00 4.20 3.41 2.51 1.58
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -35 310 272 176 145 80 82
Total Preferred & Common Equity		 -35 310 272 176 145 80 82
Total Common Equity		 -35 310 272 176 145 80 82
Common Stock		 0.89 382 389 396 451 461 513
Retained Earnings		 -35 -72 -117 -219 -306 -382 -431
Accumulated Other Comprehensive Income / (Loss)		 0.05 -0.06 -0.56 -0.88 0.00 0.00 0.01

Quarterly Balance Sheets for Shattuck Labs

This table presents Shattuck Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 130 146 129 112 77 64 100 102
Total Current Assets		 113 131 114 99 66 55 91 94
Cash & Equivalents		 41 76 61 44 61 50 43 90
Short-Term Investments		 60 39 45 46 0.00 0.00 44 0.00
Prepaid Expenses		 12 16 9.08 8.68 5.51 4.21 4.59 3.33
Plant, Property, & Equipment, net		 15 13 12 11 8.88 7.95 7.05 5.35
Total Noncurrent Assets		 2.67 2.43 2.29 2.15 1.89 1.75 2.56 3.02
Long-Term Investments		 - - - - - - - 1.00
Other Noncurrent Operating Assets		 2.67 2.43 2.29 2.15 1.89 1.75 2.56 2.02
Total Liabilities & Shareholders' Equity		 130 146 129 112 77 64 100 102
Total Liabilities		 18 18 18 15 9.58 7.35 7.09 6.29
Total Current Liabilities		 14 14 15 12 7.32 5.34 5.34 4.25
Accounts Payable		 2.02 2.15 2.82 2.93 1.53 0.48 1.16 1.25
Accrued Expenses		 12 7.57 9.21 9.47 5.78 4.86 4.17 3.00
Total Noncurrent Liabilities		 3.62 3.19 2.97 2.74 2.27 2.02 1.76 2.04
Other Noncurrent Operating Liabilities		 3.62 3.19 2.97 2.74 2.27 2.02 1.76 2.04
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 113 129 111 97 68 57 93 96
Total Preferred & Common Equity		 113 129 111 97 68 57 93 96
Total Common Equity		 113 129 111 97 68 57 93 96
Common Stock		 401 454 457 460 463 465 511 541
Retained Earnings		 -289 -325 -346 -363 -395 -408 -418 -445
Accumulated Other Comprehensive Income / (Loss)		 0.01 -0.01 -0.01 0.05 0.00 0.00 0.00 0.00

Annual Metrics And Ratios for Shattuck Labs

This table displays calculated financial ratios and metrics derived from Shattuck Labs' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 41,744,237.00 42,246,539.00 42,390,586.00 42,485,485.00 47,739,708.00 63,279,843.00
DEI Adjusted Shares Outstanding		 0.00 41,744,237.00 42,246,539.00 42,390,586.00 42,485,485.00 47,739,708.00 63,279,843.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -0.88 -1.06 -2.40 -2.05 -1.58 -0.77
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 0.48% 202.16% -97.83% 154.14% 245.26% -82.52%
EBITDA Growth		 0.00% -48.33% -12.73% -140.61% 9.77% 11.75% 38.82%
EBIT Growth		 0.00% -47.63% -22.74% -127.06% 11.17% 12.38% 36.08%
NOPAT Growth		 0.00% -47.33% -22.58% -128.26% 11.01% 12.39% 36.07%
Net Income Growth		 0.00% -52.63% -22.87% -126.68% 14.37% 13.62% 35.28%
EPS Growth		 0.00% 25.55% 54.66% -125.23% 14.94% 27.32% 53.02%
Operating Cash Flow Growth		 0.00% -60.47% -69.69% -65.45% 14.04% 25.50% 34.10%
Free Cash Flow Firm Growth		 0.00% 0.00% -142.64% -39.77% 24.52% 22.99% 33.12%
Invested Capital Growth		 0.00% -4.14% 111.65% 398.89% -5.36% -52.85% -49.92%
Revenue Q/Q Growth		 0.00% 0.00% 2,243.25% -97.85% 24.31% -11.10% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 35.45% -57.21% 4.62% -1.98% 15.21%
EBIT Q/Q Growth		 0.00% 0.00% 29.75% -49.38% 4.81% -1.89% 14.25%
NOPAT Q/Q Growth		 0.00% 0.00% 31.95% -52.39% 7.38% -0.86% 10.85%
Net Income Q/Q Growth		 0.00% 0.00% 30.63% -48.42% 8.13% -1.33% 11.09%
EPS Q/Q Growth		 0.00% 0.00% -167.50% -47.85% 8.48% 2.61% 31.37%
Operating Cash Flow Q/Q Growth		 0.00% -23.58% -8.91% -5.73% 5.16% 3.28% 18.21%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 7.26% 4.98% 3.49% 20.21%
Invested Capital Q/Q Growth		 0.00% 0.00% 110.27% 4.01% 20.25% 1.84% -53.22%
Profitability Metrics		 - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -249.10% -367.76% -137.20% -15,198.47% -5,395.78% -1,379.23% -4,827.70%
Operating Margin		 -253.53% -371.76% -150.81% -15,848.01% -5,549.61% -1,408.27% -5,150.80%
EBIT Margin		 -254.54% -373.99% -151.91% -15,879.91% -5,550.21% -1,408.56% -5,151.20%
Profit (Net Income) Margin		 -242.56% -368.46% -149.83% -15,635.74% -5,268.44% -1,318.13% -4,880.90%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 95.30% 98.52% 98.63% 98.46% 94.92% 93.58% 94.75%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -810.02% -444.59% -544.40% -723.72%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -796.24% -428.88% -525.72% -706.94%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 764.50% 390.17% 477.17% 663.47%
Return on Equity (ROE)		 -165.21% -22.57% -15.46% -45.52% -54.41% -67.23% -60.25%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -2,020.73% -943.23% -439.08% -472.57% -657.20%
Operating Return on Assets (OROA)		 -55.96% -18.86% -14.08% -41.09% -50.41% -64.31% -56.58%
Return on Assets (ROA)		 -53.33% -18.58% -13.89% -40.46% -47.85% -60.18% -53.61%
Return on Common Equity (ROCE)		 393.20% -19.15% -15.46% -45.52% -54.41% -67.23% -60.25%
Return on Equity Simple (ROE_SIMPLE)		 69.42% -11.81% -16.55% -57.87% -60.33% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -18 -26 -32 -72 -64 -56 -36
NOPAT Margin		 -177.47% -260.23% -105.57% -11,093.60% -3,884.73% -985.79% -3,605.56%
Net Nonoperating Expense Percent (NNEP)		 -16.46% -5.74% -4.40% -13.77% -15.71% -18.68% -16.78%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -44.48% -70.83% -43.76%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 58.02% 94.44% 62.37% 3,233.44% 1,165.00% 333.46% 1,723.50%
R&D to Revenue		 295.52% 377.32% 188.44% 12,714.57% 4,484.61% 1,174.81% 3,527.30%
Operating Expenses to Revenue		 353.53% 471.76% 250.81% 15,948.01% 5,649.61% 1,508.27% 5,250.80%
Earnings before Interest and Taxes (EBIT)		 -25 -37 -46 -104 -92 -81 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -25 -37 -41 -99 -89 -79 -48
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 7.06 1.32 0.55 2.09 0.73 2.80
Price to Tangible Book Value (P/TBV)		 0.00 7.06 1.32 0.55 2.09 0.73 2.80
Price to Revenue (P/Rev)		 17.19 220.24 11.98 149.54 182.81 10.10 230.97
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 30.42 0.00 12.24 0.00 45.69
Enterprise Value to Revenue (EV/Rev)		 18.20 186.47 3.02 0.00 103.98 0.00 151.91
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -2.69 -1.15 -1.04 -0.96 -0.91 -0.91 -0.94
Leverage Ratio		 3.10 1.21 1.11 1.12 1.14 1.12 1.12
Compound Leverage Factor		 2.95 1.20 1.10 1.11 1.08 1.05 1.06
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 338.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -238.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 1.22 34.07 8.16 -0.22 8.64 -4.77 8.56
Noncontrolling Interest Sharing Ratio		 338.00% 15.13% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 2.12 20.53 11.72 7.39 12.51 8.88 11.70
Quick Ratio		 1.96 19.93 10.93 6.46 11.41 8.19 11.07
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -25 -60 -84 -64 -49 -33
Operating Cash Flow to CapEx		 -4,462.77% -4,629.85% -720.62% -821.01% -19,957.74% -102,567.80% -56,171.83%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.22 0.05 0.09 0.00 0.01 0.05 0.01
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 4.06 3.65 4.64 0.05 0.11 0.48 0.13
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 -25 -26 2.98 15 14 6.64 3.33
Invested Capital Turnover		 -0.40 -0.40 -2.66 0.07 0.11 0.55 0.20
Increase / (Decrease) in Invested Capital		 0.00 -1.02 29 12 -0.80 -7.44 -3.31
Enterprise Value (EV)		 180 1,852 91 -64 172 -15 152
Market Capitalization		 170 2,188 360 97 303 58 231
Book Value per Share		 ($4.57) $7.42 $6.43 $4.16 $3.41 $1.67 $1.30
Tangible Book Value per Share		 ($4.57) $7.42 $6.43 $4.16 $3.41 $1.67 $1.30
Total Capital		 15 310 272 176 145 80 82
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -39 -335 -269 -161 -131 -73 -79
Capital Expenditures (CapEx)		 0.47 0.73 7.93 12 0.41 0.06 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -17 -6.64 -5.12 -1.66 1.14 -2.69 -2.64
Debt-free Net Working Capital (DFNWC)		 22 329 264 160 132 70 75
Net Working Capital (NWC)		 22 329 264 160 132 70 75
Net Nonoperating Expense (NNE)		 6.44 11 13 30 23 19 13
Net Nonoperating Obligations (NNO)		 -39 -335 -269 -161 -131 -73 -79
Total Depreciation and Amortization (D&A)		 0.54 0.62 4.42 4.44 2.56 1.68 3.24
Debt-free, Cash-free Net Working Capital to Revenue		 -168.19% -66.88% -17.07% -254.75% 68.92% -47.00% -264.20%
Debt-free Net Working Capital to Revenue		 227.15% 3,309.90% 878.44% 24,481.44% 7,952.14% 1,228.77% 7,542.30%
Net Working Capital to Revenue		 227.15% 3,309.90% 878.44% 24,481.44% 7,952.14% 1,228.77% 7,542.30%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 41.78M 42.03M 42.38M 42.60M 50.76M 69.58M
Adjusted Diluted Earnings per Share		 $0.00 ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 41.78M 42.03M 42.38M 42.60M 50.76M 69.58M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($2.36) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 15.51M 42.36M 42.45M 47.47M 47.90M 71.56M
Normalized Net Operating Profit after Tax (NOPAT)		 -18 -26 -32 -72 -64 -56 -36
Normalized NOPAT Margin		 -177.47% -260.23% -105.57% -11,093.60% -3,884.73% -985.79% -3,605.56%
Pre Tax Income Margin		 -242.56% -368.46% -149.83% -15,635.74% -5,268.44% -1,318.13% -4,880.90%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.27% -52.68% 0.00% 0.00% 0.00% -0.02% 0.00%

Quarterly Metrics And Ratios for Shattuck Labs

This table displays calculated financial ratios and metrics derived from Shattuck Labs' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 42,471,335.00 42,485,485.00 47,474,783.00 47,550,872.00 47,727,269.00 47,739,708.00 47,899,240.00 47,899,240.00 47,903,215.00 63,279,843.00 71,564,217.00
DEI Adjusted Shares Outstanding		 42,471,335.00 42,485,485.00 47,474,783.00 47,550,872.00 47,727,269.00 47,739,708.00 47,899,240.00 47,899,240.00 47,903,215.00 63,279,843.00 71,564,217.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.65 -0.42 -0.39 -0.45 -0.35 -0.39 -0.29 -0.26 -0.21 -0.20 -0.21
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 223.58% 83.08% 1,856.14% 704.50% 336.88% 0.00% -100.00% -100.00% -66.63% 0.00% 0.00%
EBITDA Growth		 -14.77% 16.58% 10.15% -2.90% 39.18% -7.02% 24.83% 45.64% 43.48% 37.10% -9.26%
EBIT Growth		 -11.80% 17.21% 10.71% -0.97% 39.45% -6.70% 22.23% 42.20% 39.69% 35.87% -8.03%
NOPAT Growth		 -13.35% 27.88% 7.47% -0.95% 37.34% -3.64% 28.21% 43.25% 40.20% 31.92% -8.03%
Net Income Growth		 -11.80% 30.40% 10.71% -0.97% 39.45% -5.61% 25.95% 42.20% 39.69% 32.58% -7.77%
EPS Growth		 -12.07% 31.67% 24.49% 16.00% 49.23% 9.76% 27.03% 42.86% 57.58% 86.49% 51.85%
Operating Cash Flow Growth		 40.38% 18.55% 38.93% 41.35% 3.98% 10.55% 25.55% 4.46% 44.42% 51.12% -11.57%
Free Cash Flow Firm Growth		 71.44% 58.83% 63.48% 99.79% 57.79% 49.41% 71.35% -17,412.46% -10.01% 4.15% -233.66%
Invested Capital Growth		 -18.14% -5.36% -26.17% -75.23% -44.32% -52.85% -52.84% 24.28% 9.04% -49.92% -33.97%
Revenue Q/Q Growth		 243.00% 4.08% 56.16% 44.30% 86.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -31.35% 19.46% 17.90% -18.47% 22.37% -41.73% 42.33% 9.71% 19.28% -57.72% -0.18%
EBIT Q/Q Growth		 -29.02% 18.83% 17.23% -16.47% 22.63% -43.05% 39.67% 9.08% 19.28% -52.11% -1.63%
NOPAT Q/Q Growth		 -25.72% 33.73% -5.77% -14.56% 21.96% -9.60% 26.74% 9.43% 17.77% -24.78% -16.26%
Net Income Q/Q Growth		 -29.02% 35.78% -4.62% -16.47% 22.63% -12.02% 26.64% 9.08% 19.28% -25.23% -17.26%
EPS Q/Q Growth		 -30.00% 36.92% 9.76% -13.51% 21.43% -12.12% 27.03% 11.11% 41.67% 64.29% -160.00%
Operating Cash Flow Q/Q Growth		 10.12% -16.06% 16.78% 32.44% -47.15% -8.12% 30.73% 13.31% 14.40% 4.92% -58.12%
Free Cash Flow Firm Q/Q Growth		 39.75% 28.44% 27.78% 99.34% -12,280.47% 14.23% 59.09% -303.15% 22.23% 25.27% -42.41%
Invested Capital Q/Q Growth		 -44.99% 20.25% 0.71% -62.82% 23.65% 1.84% 0.74% -2.03% 8.49% -53.22% 32.81%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 100.00% 0.00% 0.00%
EBITDA Margin		 -3,946.36% -3,053.64% -1,605.47% -1,318.02% -549.35% 0.00% 0.00% 0.00% -930.50% 0.00% 0.00%
Operating Margin		 -4,168.80% -2,654.20% -1,797.67% -1,427.10% -597.93% 0.00% 0.00% 0.00% -1,071.60% 0.00% 0.00%
EBIT Margin		 -4,014.72% -3,131.09% -1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00%
Profit (Net Income) Margin		 -4,014.72% -2,477.17% -1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 79.12% 100.00% 100.00% 100.00% 78.31% 95.21% 100.00% 100.00% 82.33% 94.99%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -299.07% -212.63% -204.66% -310.25% -295.52% 0.00% 0.00% 0.00% -110.09% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -293.82% -209.60% -201.13% -305.32% -291.20% 0.00% 0.00% 0.00% -107.19% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 269.34% 190.69% 177.69% 272.77% 265.85% 0.00% 0.00% 0.00% 99.50% 0.00% 0.00%
Return on Equity (ROE)		 -29.74% -21.95% -26.98% -37.48% -29.68% 0.00% 0.00% 0.00% -10.60% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 -514.38% -439.08% -348.72% -356.76% -556.55% -472.57% -430.77% -791.06% -602.24% -657.20% -623.07%
Operating Return on Assets (OROA)		 -30.29% -28.44% -27.81% -38.92% -29.57% 0.00% 0.00% 0.00% -9.48% 0.00% 0.00%
Return on Assets (ROA)		 -30.29% -22.50% -27.81% -38.92% -29.57% 0.00% 0.00% 0.00% -9.48% 0.00% 0.00%
Return on Common Equity (ROCE)		 -29.74% -21.95% -26.98% -37.48% -29.68% 0.00% 0.00% 0.00% -10.60% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -84.25% 0.00% -66.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -20 -13 -14 -16 -13 -14 -10 -9.12 -7.50 -9.36 -11
NOPAT Margin		 -2,918.16% -1,857.94% -1,258.37% -998.97% -418.55% 0.00% 0.00% 0.00% -750.12% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -5.26% -3.03% -3.54% -4.92% -4.32% -4.84% -4.14% -4.28% -2.90% -4.25% -5.10%
Return On Investment Capital (ROIC_SIMPLE)		 - -9.17% -10.89% -14.53% -12.99% -17.27% -14.90% -16.00% -8.05% -11.36% -11.35%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 739.50% 621.57% 439.01% 331.39% 153.62% 0.00% 0.00% 0.00% 409.80% 0.00% 0.00%
R&D to Revenue		 3,529.30% 2,132.63% 1,458.65% 1,195.71% 544.31% 0.00% 0.00% 0.00% 761.80% 0.00% 0.00%
Operating Expenses to Revenue		 4,268.80% 2,754.20% 1,897.67% 1,527.10% 697.93% 0.00% 0.00% 0.00% 1,171.60% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -28 -22 -19 -22 -17 -24 -14 -12 -10 -15 -16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -27 -22 -18 -21 -16 -23 -13 -12 -9.31 -15 -15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.57 2.09 3.29 1.66 1.72 0.73 0.67 0.67 1.23 2.80 4.80
Price to Tangible Book Value (P/TBV)		 0.57 2.09 3.29 1.66 1.72 0.73 0.67 0.67 1.23 2.80 4.80
Price to Revenue (P/Rev)		 48.43 182.81 156.33 44.51 25.88 10.10 9.88 12.65 114.49 230.97 460.16
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 12.24 21.85 14.83 11.74 0.00 0.00 0.00 3.99 45.69 83.50
Enterprise Value to Revenue (EV/Rev)		 0.00 103.98 114.10 18.96 11.89 0.00 0.00 0.00 28.36 151.91 368.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.92 -0.91 -0.88 -0.89 -0.91 -0.91 -0.89 -0.93 -0.93 -0.94 -0.93
Leverage Ratio		 1.13 1.14 1.13 1.14 1.16 1.12 1.14 1.15 1.12 1.12 1.10
Compound Leverage Factor		 1.13 0.90 1.13 1.14 1.16 0.87 1.08 1.15 1.12 0.93 1.04
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.68 10.08 11.98 2.76 2.54 -2.71 -3.96 -5.45 4.55 9.88 38.38
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.04 12.51 9.15 7.62 7.96 8.88 9.08 10.25 17.00 11.70 22.06
Quick Ratio		 7.19 11.41 8.00 7.01 7.26 8.19 8.33 9.46 16.14 11.07 21.28
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -17 -12 -9.00 -0.06 -7.35 -6.31 -2.58 -10 -8.09 -6.05 -8.61
Operating Cash Flow to CapEx		 -88,063.16% -114,229.41% 0.00% 0.00% -38,252.38% 0.00% 0.00% 0.00% -12,576.06% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.01 0.01 0.02 0.03 0.05 0.05 0.04 0.03 0.01 0.01 0.01
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.08 0.11 0.18 0.30 0.50 0.48 0.42 0.30 0.11 0.13 0.14
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12 14 14 5.27 6.52 6.64 6.69 6.55 7.11 3.33 4.42
Invested Capital Turnover		 0.10 0.11 0.16 0.31 0.71 0.55 0.44 0.51 0.15 0.20 0.18
Increase / (Decrease) in Invested Capital		 -2.60 -0.80 -5.03 -16 -5.19 -7.44 -7.49 1.28 0.59 -3.31 -2.27
Enterprise Value (EV)		 -37 172 310 78 77 -15 -15 -13 28 152 369
Market Capitalization		 65 303 424 184 167 58 46 38 114 231 460
Book Value per Share		 $2.66 $3.41 $2.71 $2.33 $2.02 $1.67 $1.41 $1.19 $1.95 $1.30 $1.34
Tangible Book Value per Share		 $2.66 $3.41 $2.71 $2.33 $2.02 $1.67 $1.41 $1.19 $1.95 $1.30 $1.34
Total Capital		 113 145 129 111 97 80 68 57 93 82 96
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -101 -131 -115 -105 -90 -73 -61 -50 -86 -79 -91
Capital Expenditures (CapEx)		 0.02 0.02 0.00 0.00 0.04 0.00 0.00 0.00 0.07 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -2.15 1.14 2.11 -5.95 -3.72 -2.69 -1.81 -1.13 -0.75 -2.64 -0.92
Debt-free Net Working Capital (DFNWC)		 99 132 117 99 86 70 59 49 85 75 90
Net Working Capital (NWC)		 99 132 117 99 86 70 59 49 85 75 90
Net Nonoperating Expense (NNE)		 7.52 4.42 4.47 5.48 4.13 4.93 3.63 3.34 2.55 3.23 3.89
Net Nonoperating Obligations (NNO)		 -101 -131 -115 -105 -90 -73 -61 -50 -86 -79 -91
Total Depreciation and Amortization (D&A)		 0.47 0.55 0.60 0.35 0.21 0.52 0.93 0.93 0.75 0.62 0.84
Debt-free, Cash-free Net Working Capital to Revenue		 -160.92% 68.92% 77.86% -144.16% -57.79% -47.00% -39.30% -37.64% -74.60% -264.20% -91.50%
Debt-free Net Working Capital to Revenue		 7,421.53% 7,952.14% 4,300.07% 2,410.26% 1,341.71% 1,228.77% 1,282.85% 1,646.28% 8,538.60% 7,542.30% 8,950.40%
Net Working Capital to Revenue		 7,421.53% 7,952.14% 4,300.07% 2,410.26% 1,341.71% 1,228.77% 1,282.85% 1,646.28% 8,538.60% 7,542.30% 8,950.40%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.65) ($0.41) ($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13)
Adjusted Weighted Average Basic Shares Outstanding		 42.48M 42.60M 50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M
Adjusted Diluted Earnings per Share		 ($0.65) ($0.41) ($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13)
Adjusted Weighted Average Diluted Shares Outstanding		 42.48M 42.60M 50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 42.49M 47.47M 47.55M 47.73M 47.74M 47.90M 47.90M 47.90M 63.28M 71.56M 76.68M
Normalized Net Operating Profit after Tax (NOPAT)		 -20 -13 -14 -16 -13 -14 -10 -9.12 -7.50 -9.36 -11
Normalized NOPAT Margin		 -2,918.16% -1,857.94% -1,258.37% -998.97% -418.55% 0.00% 0.00% 0.00% -750.12% 0.00% 0.00%
Pre Tax Income Margin		 -4,014.72% -2,477.17% -1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -0.02% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Shattuck Labs’ latest quarter shows a company that is still deeply unprofitable, but with a much stronger cash position than a year ago. In Q1 2026, STTK reported no revenue, a net loss of $14.8 million, and negative operating cash flow. At the same time, the balance sheet improved materially thanks to financing activity and investment sales, leaving the company with a sizable cash cushion.

  • Cash and equivalents rose sharply to $90.4 million at the end of Q1 2026, up from $42.5 million in Q3 2025 and $43.8 million in Q3 2024. That gives the company more runway than it had several quarters ago.
  • Shattuck had $102.1 million in total assets and only $6.3 million in total liabilities in Q1 2026, which leaves it with a relatively clean balance sheet for a development-stage biotech company.
  • Quarterly operating expenses declined year over year to $15.5 million in Q1 2026 from $20.9 million in Q3 2024, showing some expense moderation compared with earlier periods.
  • Q1 2026 financing activity brought in $20.6 million from common equity issuance, helping offset cash burn and reinforce liquidity.
  • Investment sales also supported liquidity, with $23.9 million in net cash from investing activities in Q1 2026, driven by maturities/sales of investments.
  • Revenue remains inconsistent and limited. The company reported $1.0 million in Q3 2025 revenue, but $0 revenue in Q1 2026, which suggests there is not yet a stable commercial base.
  • R&D spending remains substantial, at $10.9 million in Q1 2026. For a biotech firm, that is normal, but it also means the company is still heavily dependent on capital markets and milestone progress.
  • Non-operating income helped reduce losses in some quarters, including interest and investment income in Q1 2026. That is helpful, but it is not a substitute for core operating profitability.
  • The company is still losing money every quarter. Q1 2026 net loss was $14.8 million, following a $12.6 million loss in Q4 2025 and a $10.1 million loss in Q3 2025.
  • Operating cash flow remains negative, with Q1 2026 cash used in operations of $13.4 million. That indicates the business is still burning cash to fund its pipeline and overhead.
  • Earlier periods show significant dilution risk. STTK has repeatedly relied on common equity issuance to support its cash position, which can pressure per-share value for existing investors over time.

Bottom line: Shattuck Labs looks financially stronger from a liquidity standpoint than it did several quarters ago, but the core story has not changed much: no meaningful recurring revenue, persistent operating losses, and ongoing cash burn. The good news is the balance sheet currently appears capable of funding operations in the near term; the challenge is turning that cash into clinical or commercial progress that can justify future value creation.

07/10/26 02:32 PM ETAI Generated. May Contain Errors.

Shattuck Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Shattuck Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Shattuck Labs' net income appears to be on an upward trend, with a most recent value of -$48.81 million in 2025, rising from -$23.98 million in 2019. The previous period was -$75.41 million in 2024. Check out Shattuck Labs' forecast to explore projected trends and price targets.

Shattuck Labs' total operating income in 2025 was -$51.51 million, based on the following breakdown:
  • Total Gross Profit: $1 million
  • Total Operating Expenses: $52.51 million

Over the last 6 years, Shattuck Labs' total revenue changed from $9.89 million in 2019 to $1 million in 2025, a change of -89.9%.

Shattuck Labs' total liabilities were at $8.64 million at the end of 2025, a 24.4% decrease from 2024, and a 71.6% decrease since 2019.

In the past 6 years, Shattuck Labs' cash and equivalents has ranged from $7.01 million in 2019 to $157.90 million in 2020, and is currently $54.19 million as of their latest financial filing in 2025.

Over the last 6 years, Shattuck Labs' book value per share changed from -4.57 in 2019 to 1.30 in 2025, a change of -128.5%.


Related Companies

Financial statements for NASDAQ:STTK last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Is the fix for AI's runaway power problem your golden ticket?
The government just committed $200 billion to building computer chips on American soil - one of the largest te...
Eagle Publishing | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Jeff Brown and Marc Chaikin's latest AI prediction explained
Jeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI...
Brownstone Research | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
The window is closing
We printed 1,000 copies of this report and 688 are gone—when the last one goes out, we're pulling it offline b...
American Alternative | Sponsoredtc pixel
A Uranium Major Just Became One of Our Largest Shareholders
IsoEnergy is acquiring the Dieter Lake uranium project in Quebec - but it's not taking cash. Instead, IsoEnerg...
The Tomorrow Investor | Sponsoredtc pixel
Executive order could send gold to 6,000 per ounce
Executive Order 14330 will allow Americans to hold precious metals inside 401(k)s for the first time ever - an...
Cedar Gold Group | Sponsoredtc pixel